Recent Quarter Total Invested
$140.62 M
Recent Quarter Institutional Ownership Percentage
63.75%
Total Invested of Last Quarter
$82.90 M
Ownership Percentage of Last Quarter
64.3%
Amylyx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 4.64 M | $15.05 M | 100.00% | 6.82% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.55 M | $8.26 M | 100.00% | 3.74% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 2.13 M | $6.89 M | 100.00% | 3.12% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 2.02 M | $6.56 M | 10.97% | 2.97% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 2.00 M | $6.48 M | 33.17% | 2.94% |
| ALMITAS CAPITAL LLC | 11/14/2024 | 1.99 M | $6.44 M | 4.45% | 2.92% |
| ABRDN PLC | 10/25/2024 | 1.97 M | $6.39 M | 1,567.90% | 2.90% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.90 M | $6.15 M | 41.25% | 2.79% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 1.77 M | $5.73 M | 46.10% | 2.60% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.61 M | $5.23 M | -38.18% | 2.37% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.40 M | $4.55 M | 100.00% | 2.06% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.15 M | $3.73 M | 0.00% | 1.69% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 912,515 | $2.96 M | 91.09% | 1.34% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 880,745 | $2.85 M | 41.62% | 1.29% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 691,066 | $2.24 M | -47.17% | 1.01% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 670,594 | $2.17 M | 986.51% | 0.98% |
| ALPHA WAVE GLOBAL, LP | 11/13/2024 | 669,487 | $2.17 M | 100.00% | 0.98% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 649,079 | $2.10 M | -80.57% | 0.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 551,039 | $1.79 M | 17.53% | 0.81% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 478,440 | $1.55 M | -18.79% | 0.70% |
| MORGAN STANLEY | 11/14/2024 | 478,265 | $1.55 M | -48.27% | 0.70% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 456,816 | $1.48 M | -70.24% | 0.67% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 406,157 | $1.32 M | -8.94% | 0.60% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 367,237 | $1.19 M | -71.70% | 0.54% |
| GHOST TREE CAPITAL, LLC | 11/14/2024 | 325,000 | $1.05 M | 100.00% | 0.48% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 317,800 | $1.03 M | 41.06% | 0.47% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 309,500 | $1.00 M | -73.18% | 0.45% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 302,270 | $979,355 | -42.05% | 0.44% |
| MARSHALL WACE, LLP | 11/14/2024 | 283,986 | $920,114 | 100.00% | 0.42% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 274,551 | $889,546 | 0.00% | 0.40% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 271,800 | $880,632 | -66.51% | 0.40% |
| ALDEBARAN CAPITAL, LLC | 11/13/2024 | 269,803 | $874,162 | 0.00% | 0.40% |
| UBS GROUP AG | 11/14/2024 | 229,076 | $742,206 | 660.07% | 0.34% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 221,626 | $718,068 | 59.33% | 0.33% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 220,906 | $715,735 | 105.87% | 0.32% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 188,465 | $610,627 | 0.00% | 0.28% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 183,894 | $595,817 | -76.70% | 0.27% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 166,429 | $539,229 | 670.50% | 0.24% |
| CITADEL ADVISORS LLC | 11/14/2024 | 160,700 | $520,668 | 15.03% | 0.24% |
| STATE STREET CORP | 11/14/2024 | 154,908 | $501,902 | 0.00% | 0.23% |
| BANK OF MONTREAL /CAN/ | 11/13/2024 | 143,512 | $442,017 | 36.35% | 0.21% |
| JPMORGAN CHASE & CO | 11/08/2024 | 140,559 | $455,411 | 144.40% | 0.21% |
| MAN GROUP PLC | 11/14/2024 | 130,862 | $423,993 | 12.69% | 0.19% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 130,000 | $421,200 | 0.00% | 0.19% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 129,290 | $418,900 | -55.31% | 0.19% |
| SHAY CAPITAL LLC | 11/14/2024 | 117,328 | $380,143 | 100.00% | 0.17% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2024 | 114,534 | $371,090 | -3.74% | 0.17% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 111,728 | $361,000 | -49.33% | 0.16% |
| ALGERT GLOBAL LLC | 11/12/2024 | 106,219 | $344,000 | 328.06% | 0.16% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 100,000 | $324,000 | 0.00% | 0.15% |
Amylyx Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of AMLX shares?
During the previous two years, 140 institutional investors and hedge funds held shares of Amylyx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
TCG Crossover Management, LLC: 4.64 M
BlackRock Funding, Inc. /DE: 2.55 M
PERCEPTIVE ADVISORS LLC: 2.13 M
Alyeska Investment Group, L.P.: 2.02 M
683 Capital Management, LLC: 2 M
Almitas Capital LLC: 1.99 M
-
What percentage of Amylyx Pharmaceuticals, Inc. stock is owned by institutional investors?
63.75% of Amylyx Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at AMLX ?
Institutional investors have bought a total of 41.96 M shares in the last 24 months. This purchase volume represents approximately $221.13 M in transactions.